Anika Therapeutics Inc. (ANIK)
ANIK trades on Nasdaq in Health Care, Medical/Dental Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$20.53
+0.29% on the day
Market cap
$274.8M
Micro cap
Revenue · 2025
$112.8M
-5.9% on 2024
Net income · 2025
-$11.0M
-9.8% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | ANIK on Nasdaq |
| Sector | Health Care |
| Industry | Medical/Dental Instruments |
| Country | United States |
| IPO year | Not reported by the screener |
| SEC CIK | 0000898437 |
| SEC industry code | Surgical & Medical Instruments & Apparatus |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $112.8M |
| Net income | -$11.0M |
| Operating income | -$11.1M |
| Net margin | -9.8% |
| Operating margin | -9.8% |
| Revenue growth | -5.9% |
| Cash | $57.5M |
| Total assets | $190.3M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 2.4× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest annual report FORM 10-K | 10-K | 2026-03-03 |
| Latest quarterly / interim FORM 10-Q | 10-Q | 2026-07-29 |
| Latest current report FORM 8-K | 8-K | 2026-07-29 |
| Latest proxy | DEFA14A | 2026-06-08 |
Source: SEC EDGAR submissions feed, 1,004 recent filings. All filings on EDGAR.
Peers in Medical/Dental Instruments
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| INFU | InfuSystems Holdings Inc. | $13.49 | -0.81% | $268.7M |
| MOBI | Mobia Medical Inc. | $8.50 | -1.16% | $283.0M |
| TMCI | Treace Medical Concepts Inc. | $4.10 | 0.00% | $266.6M |
| OSUR | OraSure Technologies Inc. | $3.81 | -2.81% | $262.8M |
| PROF | Profound Medical Corp. | $7.01 | -3.31% | $256.1M |
| CLPT | ClearPoint Neuro Inc. | $9.81 | -3.82% | $299.2M |
| UTMD | Utah Medical Products Inc. | $74.71 | +0.40% | $237.9M |
| EMBC | Embecta Corp. | $6.20 | +3.51% | $351.3M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier